# Galleria mellonella as a versatile model for investigating Candida glabrata virulence and antifungal resistance

**Authors:** Charlie J. D. Holt, Catrin C. Wiliams, Jane Usher

PMC · DOI: 10.1099/jmm.0.002127 · Journal of Medical Microbiology · 2026-02-18

## TL;DR

This review explores how the greater wax moth larva, Galleria mellonella, can be used to study the virulence and antifungal resistance of the fungal pathogen Candida glabrata.

## Contribution

The paper highlights Galleria mellonella as a cost-effective, non-mammalian model for studying C. glabrata pathogenesis and antifungal efficacy.

## Key findings

- G. mellonella shows concordance with murine models and clinical outcomes in C. glabrata studies.
- The model is effective for dissecting virulence traits and screening antifungal therapies.
- Limitations include the absence of adaptive immunity in the model.

## Abstract

Candida glabrata is an opportunistic fungal pathogen and a leading cause of invasive candidiasis, particularly in immunocompromised patients, where treatment is increasingly compromised by intrinsic and acquired antifungal resistance. Despite lacking morphological plasticity, C. glabrata employs distinct virulence strategies, including adhesin-mediated host colonization, intracellular survival within phagocytes, stress tolerance, iron acquisition and biofilm formation. This review synthesizes current knowledge of C. glabrata virulence and antifungal resistance mechanisms, with a particular focus on azole and echinocandin resistance driven by efflux pump regulation and FKS mutations. We critically evaluate the greater wax moth larva, Galleria mellonella, as a non-mammalian in vivo model for studying C. glabrata pathogenesis, host–pathogen interactions and antifungal efficacy. Evidence demonstrating concordance between G. mellonella, murine models and clinical outcomes is discussed, alongside the model’s limitations, including the absence of adaptive immunity. Collectively, this review highlights G. mellonella as a robust, cost-effective platform for dissecting C. glabrata virulence traits and for preclinical screening of antifungal therapies, supporting its growing role in translational fungal research.

## Linked entities

- **Diseases:** invasive candidiasis (MONDO:0044067)
- **Species:** Galleria mellonella (taxon 7137), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** EPA7 (pseudo) [NCBI Gene 90657416]
- **Diseases:** invasive (MESH:D009361), Fungal infections (MESH:D009181), candidiasis (MESH:D002177), C. glabrata infection (MESH:D007239), deaths (MESH:D003643)
- **Chemicals:** caspofungin (MESH:D000077336), NO (MESH:D009569), beta-glucan (MESH:D047071), ROS (MESH:D017382), ibrexafungerp (MESH:C569338), Echinocandin (MESH:D054714), peptides (MESH:D010455), Iron (MESH:D007501), sterols (MESH:D013261), fluconazole (MESH:D015725), polyene (MESH:D011090), Azole (MESH:D001393), micafungin (MESH:D000077551), amphotericin B (MESH:D000666), ergosterol (MESH:D004875), haem (MESH:D006418), AMPs (MESH:D000089882), hydrogen peroxide (MESH:D006861), AmpB (-)
- **Species:** Galleria mellonella (greater wax moth, species) [taxon 7137], Candidozyma auris (species) [taxon 498019], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Nakaseomyces glabratus (species) [taxon 5478], Mus musculus (house mouse, species) [taxon 10090], Candida tropicalis (species) [taxon 5482], Pichia kudriavzevii (species) [taxon 4909], Lodderomyces parapsilosis (species) [taxon 5480], Galleria (genus) [taxon 7136], Candida albicans (species) [taxon 5476]
- **Mutations:** S663F, F659L, S629P, F659V, S663P

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916062/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916062/full.md

## References

82 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916062/full.md

---
Source: https://tomesphere.com/paper/PMC12916062